Tests a video game for attention problems in childhood cancer survivors
Tests a video game against a control game in childhood leukemia or brain tumor survivors.
Key facts
- Who runs it
- Children's National Research Institute
- Where
- Washington D.C., United StatesSee the site
- Trial code
- Registry title
- Feasibility/Acceptability of Attentional-Control Training in Survivors
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 14 Jun 2023
- Planned end
- 31 Aug 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- EndeavorRx
- Control video game
- Record updated
- 10 January 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children aged 8-16 who had acute lymphoblastic leukemia or a brain tumor and finished treatment at least 1 year ago. It tests a computer-based attention training.
- Age
- 8-16 years
- Sex
- Boys and girls
- Disease stage
- History of acute lymphoblastic leukemia (ALL) or brain tumor. At least 1 year after the end of planned therapy, with the disease stable.
- Earlier treatment
- Not taking stimulant medication for attention problems, or on a stable dose for at least 30 days before joining.
- Biomarker or test result
- To be randomized, a child needs a T-score of 75th percentile or higher on the CPT-3 Omission Errors scale or the BRIEF-2 Cognitive Regulation Index.
Main reasons for not taking part
- History of photosensitive seizures
- Motor, visual, or hearing problem that prevents computer use
- Mental health condition that blocks or takes priority over the cognitive training
- Full-scale IQ below 80 (cannot be randomized)
- Child or caregiver not fluent in spoken English
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Aged 8-16 years at time of screening
- History of diagnosis of acute lymphoblastic leukemia (ALL) or brain tumor (BT)
- At least 1 year from completion of planned therapy and stable from a disease standpoint
- Participating child and caregiver are fluent in spoken English
- Availability of a caregiver who is willing and capable of providing support and supervision during cognitive training
- Participating child is either not taking any prescribed stimulant medication for attention difficulties or has been prescribed a stable dose of stimulant medication for attention difficulties for at least 30 days prior to enrollment
- Only patients with a T-score ≥ 75th percentile on the CPT-3 Omission Errors scale or on the BRIEF-2 Cognitive Regulation Index will be randomized
Who cannot take part
- A history of photosensitive seizures
- A mental health condition that precludes, or takes treatment precedence over, participation in the cognitive training
- A motor, visual, or auditory handicap that prevents computer use
- Participants identified during the baseline assessment as having a full-scale IQ < 80, as estimated by WASI-II (Vocabulary and Matrix Reasoning), will not be randomized
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 16 years old?
Where in United States
- Children's National HospitalWashington D.C., United StatesContact: Steven Hardy, PhDTaking people
About the trial
What the trial wants to find out
This is a multicenter pilot randomized controlled trial, with an active control condition, of the feasibility, acceptability, and preliminary efficacy of EndeavorRx in a cohort of survivors of acute lymphoblastic leukemia or brain tumor ages 8-16 who are > 1 year from the end of therapy.
The 2 groups in the trial
- EndeavorRxTreatment being tested
Children will be asked to begin digital attentional control training at home within 6 weeks of baseline testing and to complete 6 training missions per day (25-30 minutes), 5 days per week, for 4 weeks (total = 120 training missions).
- ControlExisting treatment, for comparison
An active control program designed to replicate aspects of the intervention (e.g., regular use of digital device to access fun educational activities) while engaging cognitive skills not particularly involving attention.
Treatment: Control video game
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- FAACTS: Feasibility/Acceptability of Attentional-Control Training in Survivors
- Plain-language title
- Tests a video game for attention problems in childhood cancer survivorsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05528939, who can take part
- Record updated
- 10 January 2025